Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cumberland Pharmaceuticals

6.77
+0.720011.90%
Volume:727.30K
Turnover:4.80M
Market Cap:95.07M
PE:-8.79
High:7.25
Open:5.75
Low:5.56
Close:6.05
Loading ...

Cumberland Pharmaceuticals: Key Insights from Earnings Call

TIPRANKS
·
9 hours ago

Q4 2024 Cumberland Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents
·
Yesterday

Cumberland Pharmaceuticals Inc (CPIX) Q4 2024 Earnings Call Highlights: Revenue Growth and ...

GuruFocus.com
·
Yesterday

Cumberland Pharmaceuticals Reports Revenue Growth and Strategic Advances

TIPRANKS
·
Yesterday

Cumberland: Q4 Earnings Snapshot

Associated Press Finance
·
Yesterday

Cumberland Q4 Adj EPS $(0.02) Up From $(0.11) YoY, Sales $10.44M Up From $9.35M YoY

Benzinga
·
Yesterday

Cumberland Pharmaceuticals Q4 Revenue USD 10.4 Million

THOMSON REUTERS
·
Yesterday

Cumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue Growth

PR Newswire
·
Yesterday

Cumberland options imply 26.1% move in share price post-earnings

TIPRANKS
·
Yesterday

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2024 FINANCIAL RESULTS

PR Newswire
·
26 Feb

BRIEF-Cumberland Pharmaceuticals Inc -Vibativ Receives Marketing Approval In China

Reuters
·
18 Feb

Cumberland Pharmaceuticals' Pneumonia Injection Receives Approval in China

MT Newswires Live
·
18 Feb

Cumberland Pharmaceuticals Inc -Vibativ Receives Marketing Approval in China

THOMSON REUTERS
·
18 Feb

VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA

PR Newswire
·
18 Feb

Cumberland Pharmaceuticals Inc - Increases Max Aggregate Shares Offering Price to $10 Million

THOMSON REUTERS
·
15 Feb

Cumberland Pharmaceuticals' Duchenne Candidate Shows Improved Heart Function In Patients With Associated Heart Disease

Benzinga
·
05 Feb